Market Research Logo

Zimbabwe Pharmaceuticals and Healthcare Report Q4 2017

Zimbabwe Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

Zimbabwe's pharmaceutical market presents significant growth potential given itsunderdevelopment. However, a combination of economic and market challenges will ensure that it remainshighly challenging for multinational pharmaceutical firms to invest locally. As such, we expect theZimbabwean government to prioritise the local generic drug industry in order to control costs and boostdomestic drugmaker competitiveness. Besides encouraging greater investment into local drugmanufacturing, the government's pro-generic drug policy on imports will need to be altered in order toadvance local firms' position in the market.

Headline Expenditure Projections

Pharmaceuticals: USD396mn in 2016 to USD413mn in 2017; +4.3% in US dollar terms. Forecastunchanged from previous quarter.

Healthcare: USD897mn in 2016 to USD863mn in 2017; -3.9% in US dollar terms. Forecast unchangedfrom previous quarter.

Risk/Reward Index

Sub-Saharan Africa is a region with high variability of market attractiveness for innovative drugmakers.While certain markets hold significant opportunities for the commercialisation of pharmaceuticals, theregion itself lags behind global standards in all areas given its underdeveloped nature. As such, it is vitalthat companies appreciate the varying levels of investment risks and rewards that are present in the marketsin Sub-Saharan Africa. BMI's Innovative Pharmaceuticals

Risk/Reward Index

tool, which provides aglobally comparative and numerically based assessment of a market's attractiveness for companies lookingto launch a high-value drug, was established to address this.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Zimbabwe 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Zimbabwe 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Zimbabwe 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Zimbabwe 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Zimbabwe 2013-2021)
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Zimbabwe 2015-2021)
Industry Risk/Reward Index
Sub-Saharan Africa Pharmaceuticals: Small Market Sizes Weaken Attractiveness To Innovative Drugmakers
Regulatory Review
Regulatory Regime
Intellectual Property Issues
Pricing And Reimbursement Regime
Market Overview
Healthcare Sector
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution And Retail Sector
Company Profile
Datlabs
Varichem Laboratories
Demographic Forecast
Table: Population Headline Indicators (Zimbabwe 1990-2025)
Table: Key Population Ratios (Zimbabwe 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Zimbabwe 1990-2025)
Table: Population By Age Group (Zimbabwe 1990-2025)
Table: Population By Age Group % (Zimbabwe 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report